Predictive Oncology (POAI) Competitors $0.85 0.00 (-0.01%) Closing price 07/7/2025 04:00 PM EasternExtended Trading$0.86 +0.01 (+0.59%) As of 07/7/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock POAI vs. OSRH, BDMD, FEMY, VVOS, PETV, RVP, NXGL, ALUR, CLGN, and NRXSShould you be buying Predictive Oncology stock or one of its competitors? The main competitors of Predictive Oncology include OSR (OSRH), Baird Medical Investment (BDMD), Femasys (FEMY), Vivos Therapeutics (VVOS), PetVivo (PETV), Retractable Technologies (RVP), NexGel (NXGL), Allurion Technologies (ALUR), CollPlant Biotechnologies (CLGN), and NeurAxis (NRXS). These companies are all part of the "medical equipment" industry. Predictive Oncology vs. Its Competitors OSR Baird Medical Investment Femasys Vivos Therapeutics PetVivo Retractable Technologies NexGel Allurion Technologies CollPlant Biotechnologies NeurAxis Predictive Oncology (NASDAQ:POAI) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings. Which has better earnings & valuation, POAI or OSRH? OSR has lower revenue, but higher earnings than Predictive Oncology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPredictive Oncology$1.62M4.69-$12.66M-$3.05-0.28OSR-$148.95K-172.12-$2.41MN/AN/A Do analysts prefer POAI or OSRH? Predictive Oncology presently has a consensus target price of $3.00, indicating a potential upside of 252.94%. Given Predictive Oncology's stronger consensus rating and higher probable upside, research analysts clearly believe Predictive Oncology is more favorable than OSR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Predictive Oncology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00OSR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in POAI or OSRH? 9.0% of Predictive Oncology shares are held by institutional investors. Comparatively, 55.3% of OSR shares are held by institutional investors. 3.4% of Predictive Oncology shares are held by company insiders. Comparatively, 33.7% of OSR shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media prefer POAI or OSRH? In the previous week, Predictive Oncology had 1 more articles in the media than OSR. MarketBeat recorded 1 mentions for Predictive Oncology and 0 mentions for OSR. Predictive Oncology's average media sentiment score of 0.29 beat OSR's score of 0.00 indicating that Predictive Oncology is being referred to more favorably in the media. Company Overall Sentiment Predictive Oncology Neutral OSR Neutral Which has more volatility and risk, POAI or OSRH? Predictive Oncology has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, OSR has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500. Is POAI or OSRH more profitable? OSR has a net margin of 0.00% compared to Predictive Oncology's net margin of -629.68%. OSR's return on equity of -36.89% beat Predictive Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Predictive Oncology-629.68% -671.29% -132.49% OSR N/A -36.89%-19.14% SummaryOSR beats Predictive Oncology on 7 of the 13 factors compared between the two stocks. Get Predictive Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for POAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding POAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POAI vs. The Competition Export to ExcelMetricPredictive OncologyMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.59M$2.00B$5.52B$9.02BDividend YieldN/AN/A5.24%4.08%P/E Ratio-0.2835.1027.1920.04Price / Sales4.6911.80413.81108.84Price / CashN/A55.8726.2128.59Price / Book-28.338.497.925.55Net Income-$12.66M-$62.39M$3.17B$248.49M7 Day Performance2.16%1.37%1.78%4.87%1 Month Performance-9.44%1.65%1.26%6.63%1 Year Performance-18.27%5.22%33.30%20.38% Predictive Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POAIPredictive Oncology2.0752 of 5 stars$0.850.0%$3.00+252.9%-12.2%$7.59M$1.62M-0.2830Positive NewsOSRHOSRN/A$1.38+2.2%N/AN/A$26.02MN/A0.00N/AGap UpBDMDBaird Medical InvestmentN/A$3.66-6.2%N/AN/A$25.68MN/A0.00N/ANews CoverageAnalyst UpgradeHigh Trading VolumeFEMYFemasys3.8062 of 5 stars$0.97-1.4%$8.67+797.4%-16.3%$25.04M$1.63M-1.0630VVOSVivos Therapeutics0.7569 of 5 stars$3.16-3.7%$4.82+52.4%+124.8%$19.32M$15.03M-1.83160PETVPetVivoN/A$0.80+1.3%N/A+63.0%$19.17M$1.05M-1.7820Gap DownHigh Trading VolumeRVPRetractable Technologies2.0566 of 5 stars$0.64+3.1%N/A-43.8%$18.56M$33.75M-1.18240NXGLNexGel0.3988 of 5 stars$2.58+7.5%N/A+19.5%$18.37M$8.69M-5.7310Gap UpALURAllurion Technologies2.3044 of 5 stars$2.46+1.2%$22.83+828.2%-91.1%$18.12M$32.11M-0.20501News CoverageCLGNCollPlant Biotechnologies2.4857 of 5 stars$1.36-1.4%$11.50+745.6%-73.8%$17.55M$2.47M-1.1170NRXSNeurAxis3.4672 of 5 stars$2.42-2.4%$7.00+189.3%-3.6%$17.46M$2.93M-1.3219 Related Companies and Tools Related Companies OSR Competitors Baird Medical Investment Competitors Femasys Competitors Vivos Therapeutics Competitors PetVivo Competitors Retractable Technologies Competitors NexGel Competitors Allurion Technologies Competitors CollPlant Biotechnologies Competitors NeurAxis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:POAI) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free POAI Stock Alerts